Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
29 studies found for:    "glucose-6-phosphate dehydrogenase deficiency"
Show Display Options
RSS Create an RSS feed from your search for:
"glucose-6-phosphate dehydrogenase deficiency"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Comparing G6PD Tests Using Capillary Blood Versus Venous Blood
Condition: Glucose-6 Phosphate Dehydrogenase Deficiency
Intervention: Other: G6PD Test
2 Completed Pharmacokinetic and in Vitro Transmission Blocking Activities Study of Primaquine Compare to Methylene Blue in Healthy Volunteer Both G6PD Normal and G6PD Deficiency
Conditions: G6PD Normal;   G6PD Deficient;   Healthy
Intervention: Drug: Regimens (Primaquine, Methylene blue)
3 Completed Evaluation of Different G6PD Testing Platforms
Condition: Glucose-6-Phosphate Dehydrogenase Deficiency
Intervention:
4 Completed A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency
Conditions: Glucosephosphate Dehydrogenase Deficiency;   Favism
Intervention: Drug: Primaquine
5 Not yet recruiting Diet Challenge in G6PD Deficient Egyptian Children: A One- Year Prospective Single Center Study With Genotype - Phenotype Correlation
Condition: Glucose-6-Phosphate Dehydrogenase Deficiency
Intervention: Dietary Supplement: non- fava beans
6 Recruiting Efficacy of Yinzhihuang Oral Liquid on Indirect Bilirubin of Neonates With Glucose-6-phosphate Dehydrogenase Deficiency
Condition: Neonatal Hyperbilirubinemia
Intervention: Drug: Yinzhihuang Oral Liquid
7 Completed Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia
Conditions: Glucosephosphate Dehydrogenase Deficiency;   Hyperbilirubinemia;   Hemolytic Disease of Newborn
Intervention: Drug: tin mesoporphyrin
8 Completed Safety and Tolerability of Low Dose Primaquine
Conditions: Malaria, Falciparum;   G6PD Deficiency
Interventions: Drug: Dihydroartemisinin piperaquine (DHA PP);   Drug: Primaquine
9 Completed Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency
Condition: Acne Vulgaris
Interventions: Drug: ACZONE Gel, 5%;   Drug: Vehicle
10 Completed G6PD (Glucose-6-phosphate Dehydrogenase) Study to Evaluate Hemolysis Potential of TFQ (Tafenoquine)
Condition: Malaria
Interventions: Drug: Chloroquine;   Drug: Primaquine;   Drug: Tafenoquine
11 Not yet recruiting G6PD Assessment Before Primaquine for Radical Treatment of Vivax Malaria
Condition: Vivax Malaria
Interventions: Drug: Chloroquine;   Drug: Primaquine 0.25 mg/kg/day;   Drug: Primaquine 0.75 mg/kg weekly
12 Completed Erythrocyte and Adipocyte G6PD Activity Levels in Obesity
Conditions: Diabetes;   Obesity
Intervention:
13 Not yet recruiting Validation of New G6PD Point of Care Tests Against Gold Standard Quantitative
Conditions: Validation;   Biosensors;   Genotyping
Intervention:
14 Completed Determining a Tolerable Dose of Primaquine in G6PD-deficient Persons Without Malaria in Mali
Condition: Malaria
Intervention: Drug: Primaquine
15 Terminated Evaluation of the Safety of Primaquine in Combination With Dihydroartemisinin-piperaquine in G6PD Deficient Males in The Gambia
Condition: Malaria
Interventions: Drug: Dihydroartemisinin-piperaquine (DHAP) administered to G6PD deficient;   Drug: Dihydroartemisinin-piperaquine (DHAP) + 0.25 mg/kg primaquine administered to G6PD deficient;   Drug: Dihydroartemisinin-piperaquine (DHAP) + 0.4 mg/kg primaquine administered to G6PD deficient;   Drug: Dihydroartemisinin-piperaquine (DHAP) + 0.25 mg/kg primaquine administered to G6PD normal;   Drug: Dihydroartemisinin-piperaquine (DHAP) + 0.4 mg/kg primaquine administered to G6PD normal
16 Completed Safety of Primaquine + Artemether-lumefantrine in G6PD Deficient Males With an Asymptomatic Malaria Infection (SAFEPRIM)
Condition: Malaria
Interventions: Drug: Artemether-Lumefantrine (AL) + 0.25 mg/kg primaquine;   Drug: Artemether-Lumefantrine (AL) combination;   Drug: Artemether-Lumefantrine (AL) + 0.4 mg/kg primaquine
17 Completed A Study to Assess Safety of Current Standard Malaria Treatment and an Assessment of G6PD Status in South-east Bangladesh
Condition: Malaria
Interventions: Drug: chloroquine;   Drug: Artemether-lumefantrine combination;   Drug: Primaquine
18 Completed Examination of Protective Factors Against Severe Malaria
Conditions: Malaria;   Severe Malaria
Intervention:
19 Active, not recruiting A Study to Assess Current Standard Malaria Treatment Guidelines in the Republic of the Sudan
Condition: Malaria
Interventions: Drug: ASP;   Drug: SDPQ;   Drug: 14DPQ;   Drug: 14DPQ on Day 42
20 Completed Primaquine Pharmacokinetics in Lactating Women and Their Infants
Condition: Vivax Malaria
Intervention: Drug: Primaquine

   Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results    Last Page
Indicates status has not been verified in more than two years